The global Sustained Release Excipients market size is expected to be worth around US$ 3.6 billion by 2030, according to a new report by Vision Research Reports.
The global Sustained Release Excipients market size was valued at US$ 965.9 million in 2020 and is anticipated to grow at a CAGR of 10.1% during forecast period 2021 to 2030.
Increasing focus on novel drug delivery R&D and rising adoption of extended release formulations for the treatment of chronic diseases are major factors driving the market.
The use of sustained release drug formulations provides patients relief from these symptoms and helps maintain desired therapeutic drug levels in the body. In comparison to conventional drugs, sustained drug release technologies provide a wide range of benefits. Reduced dosage frequency, improved patient compliance, maintenance of the constant level of drug in blood plasma, lower instances of toxicity due to overdose, and higher cost-effectiveness, in the long run, are some of the major advantages of using this technology.
The global rise in the incidence of chronic and infectious diseases has also resulted in antibiotic resistance, which negatively affects the market for conventional dosage forms. Thus, alternative methods to manage and treat these diseases are being implemented. The use of sustained release formulations has been widely accepted among physicians in order to combat antibiotic resistance. Since these formulations create desired therapeutic drug levels in blood plasma and reduce dosage frequency, they are the preferred choice of formulation among physicians, which increases their demand.
The oral route of delivery is the most preferred route of administration. The segment is expected to lead the market throughout the forecast period. The growth of the segment can be attributed to convenience in terms of storage, premeasured doses, portability, and noninvasive nature of the route. On the other hand, transdermal patches will emerge to be the fast-growing segment during the same period.
The intramuscular route provides rapid drug delivery and absorption, owing to which the segment is poised to represent a sizeable share in the market. Intravenous administration for sustained or prolonged acting drugs, such as long-acting injectable formulations, provide several advantages including assessed drug-release profile throughout a definite period of time, ease of application, better patient compliance, reduced dosage frequency, minimum adverse effects, and overall cost reduction of medical care
Ophthalmic route of delivery is also anticipated to post a noteworthy CAGR during the forecast period owing to the increasing number of product launches aiding treatment of cytomegalovirus, chronic non-infectious posterior uveitis, and diabetic macular edema.
Various manufacturers are developing products that help diabetic patients in managing the disease better. For instance, Bydureon BCise is an extended release system that delivers exenatide in patients and is indicated for weekly use. Also, Sustol (Granisetron) manufactured by Heron Therapeutics, Inc. is another example of a subcutaneously delivered drug that is an antiemetic used for management of nausea and vomiting, typically observed in cancer patients undergoing chemotherapy.
Polymers held the largest share in the sustained release excipients market in 2017 due to their wide usage in sustained release formulations. Higher contribution of sugars in sustained release formulations can be attributed to properties such as spherical shape and porous nature, which improves flowability and lowers friability. This makes it the choice of excipient for a wide range of pharmaceuticals.
Minerals are an important class of excipients owing to properties such as reactivity to acids, swelling capacity, specific surface area, and high absorption capacity. Use of titanium oxide in Amrix, Kadian, OxyContin, and Conzip as a major excipient is indicative of the increase in the utilization of minerals in various formulations, accelerating their growth.
Increasing use of gelatin, alcohol, and chitosan in sustained release formulations is also anticipated to propel segment growth. Use of gelatin in manufacturing powder, liquid, and oil-based pastes such as solids, semisolid, and liquid forms of formulations is expected to drive the gelatin segment in the future. Sugars used in drug formulations are also applicable as drug delivery agents in pulmonary route-based formulations.
Pharmaceutical companies are involved in developing extended drug delivery systems that would allow easy administration and improve drug efficacy. As sustained drug release systems are meticulously developed according to their usage, they prove to be beneficial for geriatric and pediatric populations. These factors are expected to impel segment growth over the forecast period.
Targeted drug delivery accounted for the largest market share in 2017, as a large number of market players have a strong product portfolio. Targeted delivery involves the delivery of the drug to a preferred site of action and prevents the drug from reaching unintended regions of the body. This averts the chances of drug toxicity. Lyrica (pregabalin) is one such drug by Pfizer, Inc. It is used for diabetic, peripheral neuropathic pain and postherpetic neuralgia.
The transdermal segment is expected to exhibit the fastest CAGR during the forecast period due to its rising use for the treatment of chronic diseases such as rheumatoid arthritis and asthma. For instance, Corplex technology by Corium International, Inc. delivers small-molecule drugs through the skin, providing a simplified way to deliver drugs.
Microencapsulation has been gaining traction in the market with an increasing number of companies adopting this method to alter drug delivery mechanisms. It results in lower toxicity when compared to conventional drug delivery systems and these systems are, therefore, preferred for geriatric and pediatric patients.
The implant segment is projected to grow at a lucrative rate during the forecast period because of its advantages such as high efficiency and continuous maintenance of drug levels in a therapeutically desired range. Retisert is a sustained release implant designed by Bausch & Lomb Incorporated, which can be used for the treatment of glaucoma. The device provides ﬂuocinolone acetonide locally for a period of 2.5 years and allows a steady predetermined rate of drug to be released.
In terms of region, North America held the largest revenue share in the market owing to high investment in R&D and the availability of highly sophisticated technologies in the region. Well-developed research infrastructure and the presence of leading pharmaceutical and biopharmaceutical companies have also fueled the regional market. Moreover, the adoption of advanced technologies and growing focus on drug discovery drives this market.
There is a wide scope for growth of the market in Europe, which includes France, Spain, and Italy, due to the rising adoption of advanced drugs in these countries. Moreover, regulatory authorities, such as the European Medicines Agency (EMA) and Medicines and Healthcare Products Regulatory Agency (MHRA), are constantly working toward ensuring high safety standards and easy access to low-cost drugs.
The Asia Pacific market is expected to register the fastest growth rate due to factors such as developing healthcare infrastructure, increasing prevalence of chronic diseases, and rising demand for highly effective therapeutics. According to the Indian Council of Medical Research, in 2016, around 1.45 million new cases of cancer were diagnosed in India, and this number is estimated to reach 1.73 million by 2020.
Moreover, geographic expansion and launch of new products by leading drug manufacturers are expected to drive the Asia Pacific market. For instance, in September 2017, Dr. Reddy’s Laboratories Ltd. launched Bupropion Hydrochloride Extended-Release Tablets, 300 mg, and 150 mg, in India.
Depomed, Inc.; Coating Place, Inc.; Corium International, Inc.; Orbis Biosciences, Inc.; Capsugel; Aradigm Corporation; and Alkermes plc.
Route of Administration Outlook
Middle East & Africa
The Sustained Release Excipients market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Sustained Release Excipients market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Sustained Release Excipients market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sustained Release Excipients market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Sustained Release Excipients market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Sustained Release Excipients capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Sustained Release Excipients by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Sustained Release Excipients market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Sustained Release Excipients market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Sustained Release Excipients market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Sustained Release Excipients industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Sustained Release Excipients market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Sustained Release Excipients market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Sustained Release Excipients market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Sustained Release Excipients market. These factors have benefited the growth of the global market for Sustained Release Excipients. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Sustained Release Excipients. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Sustained Release Excipients are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
To strategically profile the key players and comprehensively analyze their growth strategies.
Medical Holography Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Biopreservation Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Biosimulation Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Hepatitis Diagnostic Test Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Nephrology And Urology Devices Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...